Drreddys Laboratories | Attività Correnti



Current Assets Cambiamento Data
ANI Pharmaceuticals USD 602.63M 66.34M 2025-06
Aurora Cannabis CAD 465.3M 28.91M 2025-06
Bayer EUR 33.75B 1.08B 2025-06
Canopy Growth CAD 303.36M 37.72M 2025-06
Cipla INR 232.89B 23.43B 2025-03
Corcept Therapeutics USD 443.11M 4.61M 2025-06
Drreddys Laboratories INR 269.9B 16.88B 2025-06
GlaxoSmithKline GBP 17.67B 412M 2025-06
Hikma Pharmaceutical USD 2.26B 22M 2024-12
Lonza CHF 5.44B 113M 2024-12
Novartis USD 25.94B 831M 2025-06
Pacira USD 745.61M 14.35M 2025-06
Prestige Brands USD 480.52M 32.19M 2025-06
Richter Gedeon HUF 641.06B 69.19B 2024-12
Sun Pharmaceuticals INR 525.94B 64.89B 2025-03
Supernus Pharmaceuticals USD 738.87M 51.28M 2025-06
Teva Pharmaceutical Industries USD 12.62B 1.09B 2025-06


Drreddys Laboratories Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Sep 2025.